Barclays raised the firm’s price target on Kodiak Sciences (KOD) to $4 from $3 and keeps an Underweight rating on the shares. The firm says the company’s Q3 highlighted recent progress and provided update across key pipeline programs.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.